Skip to main content
. 2005 Jan 18;6:2. doi: 10.1186/1471-2121-6-2

Figure 2.

Figure 2

Mean number of C2 positive and C2 negative cells for each treatment condition. C2 positive cells are boxed in gray and C2 negative cells in stripes. Note that IGF-II analog reduces C2 positive cells when compared to SFM, whereas both NBI 31772 and R3-IGF-I significantly increase C2 positive and total cell abundance when compared to SFM (*** = p < 0.01, ** = p < 0.05, * = p < 0.1). In contrast, no treatment significantly altered C2 negative cell abundance.